News Releases

Rubicon Genomics Expands Asia Distribution; 2016 AACR Data Presentation Shows Utility of ThruPLEX® Plasma-seq Cell-Free NGS Libraries From Liquid Biopsies
--Partnering with MDL Asia to Leverage Its Extensive Regional Relationships and Expand Availability of Rubicon DNA Library Preparation Kits in China--
--At AACR 2016 Spotlight Workshop Co-Hosted by Beckman Coulter, TGen's Muhammed Murtaza to Speak on Use of ThruPLEX in Translational Cancer Research--
--Rubicon Reports Robust Increase in Q1 Sales, with Revenues on Track to Grow More than 40% in 2016--

NEW ORLEANS, and ANN ARBOR, Mich., April 12 2016 /PRNewswire/ -- Rubicon Genomics, Inc., a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency and speed of genomic analysis, today announced an agreement with MDL Asia to expand its presence in the Chinese market.  MDL Asia will leverage its extensive knowledge of the life science and diagnostics markets in China to network with distributors to increase the availability of ThruPLEX® Plasma-seq and other DNA library preparation kits. MDL Asia is a leading consultancy that helps small and medium-sized life sciences innovators broaden their distribution networks across the Asia Pacific region.

Separately, Rubicon announced a number of activities at the upcoming American Association for Cancer Research (AACR) 2016 Annual Meeting, including an Exhibitor Spotlight Presentation co-hosted by Beckman Coulter Life Sciences, a poster presentation confirming the utility of its ThruPLEX Plasma-seq kit for preparation of cell-free DNA libraries from liquid biopsies, and an Exhibitor's Booth (#2838.) Earlier this year Rubicon announced a non-exclusive distribution agreement in the US and Canada with Beckman Coulter Life Sciences for ThruPLEX Plasma-seq kits for research.

Additionally, Rubicon reported that based on its first quarter results, for the fourth consecutive year the company expects to post sales gains of greater than 40% in 2016. Rubicon CEO James Koziarz, PhD, commented, "Rubicon is off to a strong start in 2016, as exemplified by our new agreement with MDL Asia to expand our distribution in key Asia Pacific growth markets and our higher profile at important industry events such as the AACR Annual Meeting. In addition, we are announcing today that our revenue for the first quarter of 2016 was approximately double the revenue we received in the first quarter of 2015. We're pleased to see the continued strong acceptance of our single cell and cell-free library prep kits in the marketplace and we expect to continue to realize our annual revenue growth target of 40% or more, which Rubicon has achieved every year since 2012."

The Spotlight Presentation: ThruPLEX® Plasma-seq--Fast and Reproducible NGS Library Preparation for Cell-free DNA from Liquid Biopsies, is sponsored by Beckman Coulter Life Sciences. Dr. Muhammed Murtaza, a leader in sequencing cell-free DNA to understand genomic alterations in cancer, will be a speaker at the presentation, which is scheduled from 10:00-11:00 AM on April 19 in Exhibitor Spotlight Theater B, Exhibit Halls G-J. In 2015, Rubicon announced that its ThruPLEX Plasma-seq kit had been automated on Beckman Coulter's Biomek FXP Liquid Handling Workstation, to provide a standardization and high-throughput processing solution.

Rubicon scientist Dr. Kamran Shazand will present data at the AACR 2016 meeting further highlighting the research utility of ThruPLEX Plasma-seq for constructing cell-free libraries that are capable of detecting alleles at low frequencies. Rubicon's poster #3621, High Efficiency Detection of Low Frequency Alleles in Cell-free DNA, Section 6, Poster Board #20, will be presented on April 19, 2016 from 1:00 to 5:00 PM.

For more information about Rubicon products, visit

About Rubicon Genomics
Rubicon Genomics develops innovative, high quality, nucleic acid library preparation and companion products for research applications that enable easy, reliable, and highly sensitive analysis of samples. Rubicon is committed to teamwork and continuous improvement to provide excellence to our customers, shareholders, and employees. Privately-held Rubicon is located in Ann Arbor, Michigan. For more information, visit

About MDL Asia
MDL Asia was established to provide small to medium-sized organisations in the Medical, Diagnostics and Life Science markets affordable opportunities for expansion into the rapidly growing and profitable Asia Pacific region. MDL Asia aims to create and manage partnerships by providing high quality business services and outcomes from our experienced management team located throughout Asia Pacific. MDL actively works with a number of International manufacturers via its network of Asia Pacific distributors to create significant revenue returns, with the goal of establishing long term successful partnerships. For more information, visit

Contacts:                                                Media
Rubicon Genomics                                  Barbara Lindheim              
Jamie Wibbenmeyer, PhD                        BLL Partners, LLC              
Business Development                             (212) 584-2276               

SOURCE Rubicon Genomics, Inc.